TAYLOR LANGSTON: Open Payments
NPI 1336495134 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,091 in 140 payments from 40 companies in 2025. Trend: 2023 $1,336 · 2024 $352 · 2025 $3,091
Food & beverage: $3,091
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 14 | $342 |
| Novartis Pharmaceuticals Corporation | 13 | $203 |
| AstraZeneca Pharmaceuticals LP | 7 | $190 |
| Janssen Biotech, Inc. | 9 | $174 |
| Incyte Corporation | 9 | $172 |
| Eisai Inc. | 9 | $161 |
| GlaxoSmithKline, LLC. | 5 | $130 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $129 |
| SOBI, INC | 3 | $122 |
| ABBVIE INC. | 5 | $118 |
Products named: KEYTRUDA, IMFINZI, Lenvima, BRUKINSA, Nubeqa, Vonjo, JAKAFI, KISQALI.
Industry payments across FL — which companies pay providers there.
